Novartis AG is 113.2x more valuable than Kailera Therapeutics, Inc. by market capitalization ($283.13 B vs $2.50 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | KLRA | NVS |
|---|---|---|
| Market cap | $2.50 B | $283.13 B |
| US-listed rank | #1950 | #47 |
| SEC filings | 52 | 947 |
Novartis AG is 113.2x more valuable than Kailera Therapeutics, Inc. by market capitalization ($283.13 B vs $2.50 B).
Full pages: Kailera Therapeutics, Inc. and Novartis AG, or browse the full rankings.